Success Metrics

Clinical Success Rate
76.9%

Based on 10 completed trials

Completion Rate
77%(10/13)
Active Trials
9(31%)
Results Posted
30%(3 trials)
Terminated
3(10%)

Phase Distribution

Ph phase_2
9
31%
Ph not_applicable
15
52%

Phase Distribution

0

Early Stage

9

Mid Stage

0

Late Stage

Phase Distribution24 total trials
Phase 2Efficacy & side effects
9(37.5%)
N/ANon-phased studies
15(62.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

76.9%

10 of 13 finished

Non-Completion Rate

23.1%

3 ended early

Currently Active

9

trials recruiting

Total Trials

29

all time

Status Distribution
Active(10)
Completed(10)
Terminated(3)
Other(6)

Detailed Status

Completed10
unknown6
Recruiting5
Active, not recruiting4
Terminated3
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
29
Active
9
Success Rate
76.9%
Most Advanced
Phase 2

Trials by Phase

Phase 29 (37.5%)
N/A15 (62.5%)

Trials by Status

completed1034%
enrolling_by_invitation13%
recruiting517%
terminated310%
unknown621%
active_not_recruiting414%

Recent Activity

Clinical Trials (29)

Showing 20 of 29 trialsScroll for more
NCT01737619Not Applicable

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

Active Not Recruiting
NCT04559139Phase 2

Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer

Active Not Recruiting
NCT05581589Phase 2

Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer

Terminated
NCT04889924Not Applicable

ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer

Recruiting
NCT05836584Phase 2

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer

Active Not Recruiting
NCT02658565Not Applicable

Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation

Active Not Recruiting
NCT07139951Phase 2

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for the Treatment of Patients With Gastric and Gastroesophageal Junction Adenocarcinoma at High Risk of Peritoneal Recurrence

Enrolling By Invitation
NCT04175431Phase 2

Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study

Recruiting
NCT06990737Phase 2

Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck

Recruiting
NCT03366051Not Applicable

Sentinel Node Mapping in High Risk Endometrial Cancer

Recruiting
NCT06385912

Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer

Completed
NCT05048173

Sentinel Lymph Node Biopsy Versus Lymphadenectomy in Endometrial Cancer

Completed
NCT01807936Not Applicable

Esophagectomy:Three-field Versus Two-field Lymphadenectomy (ECTOP-2002)

Completed
NCT03796819Not Applicable

Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma

Completed
NCT01512810Phase 2

Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer

Completed
NCT01406769Phase 2

Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy

Completed
NCT04778826Not Applicable

Immune Response Following Lobectomy Along With or Without Bilateral Transcervical Mediastinal Lymphadenectomy

Unknown
NCT04581122Not Applicable

A Multiple-center Study on the Effect of Different Ways of Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With More Than 50% Solid Components

Recruiting
NCT01939028Not Applicable

Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery

Terminated
NCT04419935

Lymphadenectomy in NSCLC With and Without Adjuvant Therapy

Unknown

Drug Details

Intervention Type
PROCEDURE
Total Trials
29